Skip to main content


Freshfields advises Agilent on acquisition of Resolution Bioscience

Freshfields is advising Agilent (NYSE: A) on its acquisition of Resolution Bioscience. The combination brings together Resolution Bioscience’s noninvasive liquid biopsy platform that improves cancer diagnostics with Agilent’s leadership in tissue-based companion diagnostics and global commercial and regulatory scale. Agilent will pay $550 million in cash at closing and up to an additional $145 million based on achieving future performance milestones. The transaction is expected to close early in the second quarter of 2021.

Agilent is a global leader in the life-sciences, diagnostics, and applied-chemical markets and is headquartered in Santa Clara, California.

More details about the transaction can be found here.

The Freshfields corporate team is led by counsel Jonathan Zhou and includes associates Brianna Cummings, Briony Driscoll, Paul Gray, Sophia Berger and Laurie Morgan, as well as partners Ethan Klingsberg and John Fisher. Partner Maj Vaseghi and senior associate Sarah Ghulamhussain are advising on compensation and benefits matters.


About Freshfields Bruckhaus Deringer LLP

Freshfields Bruckhaus Deringer LLP is a global elite law firm with a long-standing track record of successfully supporting the world's leading national and multinational corporations, financial institutions and governments on groundbreaking and business-critical mandates. Our 2,800-plus lawyers deliver results worldwide through our own offices and alongside leading local firms. Our commitment, local and multinational expertise, and business know-how means our clients rely on us when it matters most.

Freshfields is ranked by Chambers Global in Band 1 across the six areas of antitrust, corporate/M&A, litigation, international arbitration, tax, and public international law. For more information visit

This material is for general information only and is not intended to provide legal advice. Prior results do not guarantee a similar outcome.